Access cutting-edge nasopharyngeal cancer treatment through this clinical trial at a research site in Dublin. Study-provided care at no cost to qualified participants.
Access nasopharyngeal cancer specialists in Dublin at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nasopharyngeal cancer treatment provided free
This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to other places in the body (metastatic). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. The usual approach of treatment is initial treatment with chemotherapy such as the co
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this nasopharyngeal cancer clinical trial in Dublin, CA
If you're searching for nasopharyngeal cancer treatment options in Dublin, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dublin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasopharyngeal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.